Lista de obras - E Smits - Dominio Público Uruguay

Abundant expression of TIM-3, LAG-3, PD-1 and PD-L1 as immunotherapy checkpoint targets in effusions of mesothelioma patients

artículo científico publicado en 2017

Acute myeloid leukemic cell lines loaded with synthetic dsRNA trigger IFN-gamma secretion by human NK cells.

artículo científico publicado en 2008

Altered CD4 T cell immunity in nurses occupationally exposed to viral pathogens

artículo científico publicado en 2018

Anti-cancer capacity of plasma-treated PBS: effect of chemical composition on cancer cell cytotoxicity

artículo científico publicado en 2017

Application of the pMHC Array to Characterise Tumour Antigen Specific T Cell Populations in Leukaemia Patients at Disease Diagnosis.

artículo científico publicado en 2015

BDCA1+CD14+ Immunosuppressive Cells in Cancer, a Potential Target?

artículo científico publicado en 2018

Bisphosphonates for cancer treatment: Mechanisms of action and lessons from clinical trials.

artículo científico publicado en 2015

Building a Bridge between Chemotherapy and Immunotherapy in Malignant Pleural Mesothelioma: Investigating the Effect of Chemotherapy on Immune Checkpoint Expression ⬇️

artículo científico publicado en 2019

CD56 Homodimerization and Participation in Anti-Tumor Immune Effector Cell Functioning: A Role for Interleukin-15

scientific article published on 22 July 2019

CD56 in the Immune System: More Than a Marker for Cytotoxicity?

artículo científico publicado en 2017

CD70 and PD-L1 in anaplastic thyroid cancer - promising targets for immunotherapy

artículo científico publicado en 2017

CD70: An emerging target in cancer immunotherapy

artículo científico

Can cervical cancer screening be stopped at 50? The prevalence of HPV in elderly women.

artículo científico publicado en 2004

Characterization of Interleukin-15-Transpresenting Dendritic Cells for Clinical Use.

artículo científico publicado en 2017

Clinical use of dendritic cells for cancer therapy.

artículo científico publicado en 2014

Clinically Relevant Chemotherapeutics Have the Ability to Induce Immunogenic Cell Death in Non-Small Cell Lung Cancer

scientific article published on 16 June 2020

Cold Atmospheric Plasma Treatment for Pancreatic Cancer-The Importance of Pancreatic Stellate Cells

scientific article published on 28 September 2020

Cold Atmospheric Plasma-Treated PBS Eliminates Immunosuppressive Pancreatic Stellate Cells and Induces Immunogenic Cell Death of Pancreatic Cancer Cells

scientific article published on 19 October 2019

Combining top-ranked immunotherapeutics in lung cancer

artículo científico publicado en 2018

Creating a robust framework for the analysis of cryopreserved samples in quantitative immunological experiments

artículo científico publicado en 2013

Dendritic Cell-Based and Other Vaccination Strategies for Pediatric Cancer

artículo científico publicado en 2019

Dendritic Cells and Programmed Death-1 Blockade: A Joint Venture to Combat Cancer.

artículo científico publicado en 2018

Dendritic Cells as Pharmacological Tools for Cancer Immunotherapy.

artículo científico

Dendritic Cells as Vaccines: Key Regulators of Tolerance and Immunity

artículo científico publicado en 2016

Dendritic cell vaccine therapy for acute myeloid leukemia: questions and answers

artículo científico publicado en 2011

Dendritic cell-based cancer gene therapy.

scientific article published on October 2009

Dendritic cells in the pathogenesis and treatment of human diseases: a Janus Bifrons?

artículo científico publicado en 2011

Desirable cytolytic immune effector cell recruitment by interleukin-15 dendritic cells.

artículo científico publicado en 2017

Desmoid tumors display a strong immune infiltration at the tumor margins and no PD-L1-driven immune suppression

artículo científico publicado en 2019

Efficient and Non-genotoxic RNA-Based Engineering of Human T Cells Using Tumor-Specific T Cell Receptors With Minimal TCR Mispairing

artículo científico publicado en 2018

Engineering monocyte-derived dendritic cells to secrete interferon-α enhances their ability to promote adaptive and innate anti-tumor immune effector functions.

artículo científico publicado en 2015

Expansion of a BDCA1+CD14+ Myeloid Cell Population in Melanoma Patients May Attenuate the Efficacy of Dendritic Cell Vaccines.

artículo científico publicado en 2016

Exploring the impact of exposure to primary varicella in children on varicella-zoster virus immunity of parents

artículo científico publicado en 2011

Generation and Cryopreservation of Clinical Grade Wilms' Tumor 1 mRNA-Loaded Dendritic Cell Vaccines for Cancer Immunotherapy.

artículo científico publicado en 2016

Generation of a cord blood-derived Wilms Tumor 1 dendritic cell vaccine for AML patients treated with allogeneic cord blood transplantation.

artículo científico publicado en 2015

HPV vaccine stimulates cytotoxic activity of killer dendritic cells and natural killer cells against HPV-positive tumour cells

artículo científico publicado en 2014

Human blood myeloid and plasmacytoid dendritic cells cross activate each other and synergize in inducing NK cell cytotoxicity.

artículo científico publicado en 2016

Human plasmacytoid dendritic cells are equipped with antigen-presenting and tumoricidal capacities.

artículo científico publicado en 2012

Hypoxia-Induced Cisplatin Resistance in Non-Small Cell Lung Cancer Cells Is Mediated by HIF-1α and Mutant p53 and Can Be Overcome by Induction of Oxidative Stress.

artículo científico publicado en 2018

IL-15 receptor alpha as the magic wand to boost the success of IL-15 antitumor therapies: The upswing of IL-15 transpresentation.

artículo científico publicado en 2016

Identification of a Wilms' tumor 1-derived immunogenic CD4(+) T-cell epitope that is recognized in the context of common Caucasian HLA-DR haplotypes.

artículo científico publicado en 2012

Identification of survivin as a promising target for the immunotherapy of adult B-cell acute lymphoblastic leukemia

artículo científico publicado en 2017

Immune Checkpoint Modulation in Colorectal Cancer: What's New and What to Expect

artículo científico publicado en 2015

Immunotherapy of acute myeloid leukemia: current approaches.

scientific article published on 16 March 2009

Immunotherapy: is a minor god yet in the pantheon of treatments for lung cancer?

artículo científico publicado en 2014

Inborn errors in RNA polymerase III underlie severe varicella zoster virus infections

artículo científico

Increased herpes zoster risk associated with poor HLA-A immediate early 62 protein (IE62) affinity.

artículo científico publicado en 2017

Induction of complete and molecular remissions in acute myeloid leukemia by Wilms' tumor 1 antigen-targeted dendritic cell vaccination

artículo científico publicado en 2010

Influence of Cell Type and Culture Medium on Determining Cancer Selectivity of Cold Atmospheric Plasma Treatment

scientific article published on 01 September 2019

Influence of frequent infectious exposures on general and varicella-zoster virus-specific immune responses in pediatricians

artículo científico publicado en 2014

Interferon-α in acute myeloid leukemia: an old drug revisited ⬇️

artículo científico publicado el 28 de enero de 2011

Interleukin-15 Dendritic Cells Harness NK Cell Cytotoxic Effector Function in a Contact- and IL-15-Dependent Manner

artículo científico publicado en 2015

Interleukin-15 enhances the proliferation, stimulatory phenotype, and antitumor effector functions of human gamma delta T cells

artículo científico publicado en 2016

Interleukin-15-Cultured Dendritic Cells Enhance Anti-Tumor Gamma Delta T Cell Functions through IL-15 Secretion.

artículo científico publicado en 2018

Interleukin-15-induced CD56(+) myeloid dendritic cells combine potent tumor antigen presentation with direct tumoricidal potential

artículo científico publicado en 2012

Interleukin-15: new kid on the block for antitumor combination therapy.

artículo científico publicado en 2014

Loading of acute myeloid leukemia cells with poly(I:C) by electroporation.

artículo científico publicado en 2014

Mass Spectrometry Imaging Reveals Neutrophil Defensins as Additional Biomarkers for Anti-PD-(L)1 Immunotherapy Response in NSCLC Patients

scientific article published on 02 April 2020

Medical costs of treatment and survival of patients with acute myeloid leukemia in Belgium

artículo científico publicado en 2016

Memory CD4 T cell receptor repertoire data mining as a tool for identifying cytomegalovirus serostatus

scientific article published on 15 June 2018

Modifying the Tumour Microenvironment: Challenges and Future Perspectives for Anticancer Plasma Treatments

artículo científico publicado en 2019

Monocyte-Derived Dendritic Cells with Silenced PD-1 Ligands and Transpresenting Interleukin-15 Stimulate Strong Tumor-Reactive T-cell Expansion

artículo científico publicado en 2017

Multidisciplinary study of the secondary immune response in grandparents re-exposed to chickenpox

artículo científico publicado en 2017

NK cells: key to success of DC-based cancer vaccines?

artículo científico

Natural killer cell immune escape in acute myeloid leukemia.

artículo científico publicado en 2012

Natural killer cells and their therapeutic role in pancreatic cancer: A systematic review.

artículo científico publicado en 2018

New targets for therapy: antigen identification in adults with B-cell acute lymphoblastic leukaemia

artículo científico publicado en 2020

Non-Thermal Plasma as a Unique Delivery System of Short-Lived Reactive Oxygen and Nitrogen Species for Immunogenic Cell Death in Melanoma Cells

scientific article published on 28 January 2019

Oxidative Stress-Inducing Anticancer Therapies: Taking a Closer Look at Their Immunomodulating Effects

artículo científico publicado en 2020

Poly(I:C) as cancer vaccine adjuvant: knocking on the door of medical breakthroughs.

artículo científico

Poly(I:C) enhances the susceptibility of leukemic cells to NK cell cytotoxicity and phagocytosis by DC

artículo científico publicado en 2011

Poly(I:C) primes primary human glioblastoma cells for an immune response invigorated by PD-L1 blockade

artículo científico publicado en 2017

Preclinical data on the combination of cisplatin and anti-CD70 therapy in non-small cell lung cancer as an excellent match in the era of combination therapy.

artículo científico publicado en 2017

Prognostic and predictive aspects of the tumor immune microenvironment and immune checkpoints in malignant pleural mesothelioma

artículo científico publicado en 2016

Proinflammatory response of human leukemic cells to dsRNA transfection linked to activation of dendritic cells

artículo científico publicado en 2007

Quantification of IFN-gamma produced by human purified NK cells following tumor cell stimulation: comparison of three IFN-gamma assays.

artículo científico publicado en 2009

RANK-RANKL Signaling in Cancer of the Uterine Cervix: A Review. ⬇️

artículo científico publicado en 2019

RANK/RANKL signaling inhibition may improve the effectiveness of checkpoint blockade in cancer treatment

artículo científico publicado en 2018

RNA-based gene transfer for adult stem cells and T cells.

artículo científico publicado en 2004

Reduction of Human Glioblastoma Spheroids Using Cold Atmospheric Plasma: The Combined Effect of Short- and Long-Lived Reactive Species

scientific article published on 23 October 2018

Ribonucleic Acid Engineering of Dendritic Cells for Therapeutic Vaccination: Ready 'N Able to Improve Clinical Outcome?

scientific article published on 27 January 2020

Sampling site matters when counting lymphocyte subpopulations

artículo científico publicado en 2012

Screening a Broad Range of Solid and Haematological Tumour Types for CD70 Expression Using a Uniform IHC Methodology as Potential Patient Stratification Method

scientific article published on 22 October 2019

Targeting immune checkpoints: New opportunity for mesothelioma treatment?

artículo científico

The potential and controversy of targeting STAT family members in cancer

artículo científico publicado en 2019

The role of the common gamma-chain family cytokines in γδ T cell-based anti-cancer immunotherapy

artículo científico publicado en 2018

The tumor-associated antigen RHAMM (HMMR/CD168) is expressed by monocyte-derived dendritic cells and presented to T cells

artículo científico publicado en 2016

Transcriptome profiling in blood before and after hepatitis B vaccination shows significant differences in gene expression between responders and non-responders

article

Transpresentation of interleukin-15 by IL-15/IL-15Rα mRNA-engineered human dendritic cells boosts antitumoral natural killer cell activity.

artículo científico publicado en 2015

Tumoricidal activity of human dendritic cells.

artículo científico publicado en 2013

Unlocking the potential of CD70 as a novel immunotherapeutic target for non-small cell lung cancer

artículo científico publicado en 2015

Unveiling a CD70-positive subset of cancer-associated fibroblasts marked by pro-migratory activity and thriving regulatory T cell accumulation

scientific article published on 19 March 2018

Vaccine and immune cell therapy in non-small cell lung cancer.

artículo científico publicado en 2018

Viral infections following allogeneic stem cell transplantation: how to cure the cure?

artículo científico publicado en 2010

mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patients.

artículo científico publicado en 2012

Lista de obras de E Smits

Abundant expression of TIM-3, LAG-3, PD-1 and PD-L1 as immunotherapy checkpoint targets in effusions of mesothelioma patients

Acute myeloid leukemic cell lines loaded with synthetic dsRNA trigger IFN-gamma secretion by human NK cells.

Altered CD4 T cell immunity in nurses occupationally exposed to viral pathogens

Anti-cancer capacity of plasma-treated PBS: effect of chemical composition on cancer cell cytotoxicity

Application of the pMHC Array to Characterise Tumour Antigen Specific T Cell Populations in Leukaemia Patients at Disease Diagnosis.

BDCA1+CD14+ Immunosuppressive Cells in Cancer, a Potential Target?

Bisphosphonates for cancer treatment: Mechanisms of action and lessons from clinical trials.

Building a Bridge between Chemotherapy and Immunotherapy in Malignant Pleural Mesothelioma: Investigating the Effect of Chemotherapy on Immune Checkpoint Expression ⬇️

CD56 Homodimerization and Participation in Anti-Tumor Immune Effector Cell Functioning: A Role for Interleukin-15

CD56 in the Immune System: More Than a Marker for Cytotoxicity?

CD70 and PD-L1 in anaplastic thyroid cancer - promising targets for immunotherapy

CD70: An emerging target in cancer immunotherapy

Can cervical cancer screening be stopped at 50? The prevalence of HPV in elderly women.

Characterization of Interleukin-15-Transpresenting Dendritic Cells for Clinical Use.

Clinical use of dendritic cells for cancer therapy.

Clinically Relevant Chemotherapeutics Have the Ability to Induce Immunogenic Cell Death in Non-Small Cell Lung Cancer

Cold Atmospheric Plasma Treatment for Pancreatic Cancer-The Importance of Pancreatic Stellate Cells

Cold Atmospheric Plasma-Treated PBS Eliminates Immunosuppressive Pancreatic Stellate Cells and Induces Immunogenic Cell Death of Pancreatic Cancer Cells

Combining top-ranked immunotherapeutics in lung cancer

Creating a robust framework for the analysis of cryopreserved samples in quantitative immunological experiments

Dendritic Cell-Based and Other Vaccination Strategies for Pediatric Cancer

Dendritic Cells and Programmed Death-1 Blockade: A Joint Venture to Combat Cancer.

Dendritic Cells as Pharmacological Tools for Cancer Immunotherapy.

Dendritic Cells as Vaccines: Key Regulators of Tolerance and Immunity

Dendritic cell vaccine therapy for acute myeloid leukemia: questions and answers

Dendritic cell-based cancer gene therapy.

Dendritic cells in the pathogenesis and treatment of human diseases: a Janus Bifrons?

Desirable cytolytic immune effector cell recruitment by interleukin-15 dendritic cells.

Desmoid tumors display a strong immune infiltration at the tumor margins and no PD-L1-driven immune suppression

Efficient and Non-genotoxic RNA-Based Engineering of Human T Cells Using Tumor-Specific T Cell Receptors With Minimal TCR Mispairing

Engineering monocyte-derived dendritic cells to secrete interferon-α enhances their ability to promote adaptive and innate anti-tumor immune effector functions.

Expansion of a BDCA1+CD14+ Myeloid Cell Population in Melanoma Patients May Attenuate the Efficacy of Dendritic Cell Vaccines.

Exploring the impact of exposure to primary varicella in children on varicella-zoster virus immunity of parents

Generation and Cryopreservation of Clinical Grade Wilms' Tumor 1 mRNA-Loaded Dendritic Cell Vaccines for Cancer Immunotherapy.

Generation of a cord blood-derived Wilms Tumor 1 dendritic cell vaccine for AML patients treated with allogeneic cord blood transplantation.

HPV vaccine stimulates cytotoxic activity of killer dendritic cells and natural killer cells against HPV-positive tumour cells

Human blood myeloid and plasmacytoid dendritic cells cross activate each other and synergize in inducing NK cell cytotoxicity.

Human plasmacytoid dendritic cells are equipped with antigen-presenting and tumoricidal capacities.

Hypoxia-Induced Cisplatin Resistance in Non-Small Cell Lung Cancer Cells Is Mediated by HIF-1α and Mutant p53 and Can Be Overcome by Induction of Oxidative Stress.

IL-15 receptor alpha as the magic wand to boost the success of IL-15 antitumor therapies: The upswing of IL-15 transpresentation.

Identification of a Wilms' tumor 1-derived immunogenic CD4(+) T-cell epitope that is recognized in the context of common Caucasian HLA-DR haplotypes.

Identification of survivin as a promising target for the immunotherapy of adult B-cell acute lymphoblastic leukemia

Immune Checkpoint Modulation in Colorectal Cancer: What's New and What to Expect

Immunotherapy of acute myeloid leukemia: current approaches.

Immunotherapy: is a minor god yet in the pantheon of treatments for lung cancer?

Inborn errors in RNA polymerase III underlie severe varicella zoster virus infections

Increased herpes zoster risk associated with poor HLA-A immediate early 62 protein (IE62) affinity.

Induction of complete and molecular remissions in acute myeloid leukemia by Wilms' tumor 1 antigen-targeted dendritic cell vaccination

Influence of Cell Type and Culture Medium on Determining Cancer Selectivity of Cold Atmospheric Plasma Treatment

Influence of frequent infectious exposures on general and varicella-zoster virus-specific immune responses in pediatricians

Interferon-α in acute myeloid leukemia: an old drug revisited ⬇️

Interleukin-15 Dendritic Cells Harness NK Cell Cytotoxic Effector Function in a Contact- and IL-15-Dependent Manner

Interleukin-15 enhances the proliferation, stimulatory phenotype, and antitumor effector functions of human gamma delta T cells

Interleukin-15-Cultured Dendritic Cells Enhance Anti-Tumor Gamma Delta T Cell Functions through IL-15 Secretion.

Interleukin-15-induced CD56(+) myeloid dendritic cells combine potent tumor antigen presentation with direct tumoricidal potential

Interleukin-15: new kid on the block for antitumor combination therapy.

Loading of acute myeloid leukemia cells with poly(I:C) by electroporation.

Mass Spectrometry Imaging Reveals Neutrophil Defensins as Additional Biomarkers for Anti-PD-(L)1 Immunotherapy Response in NSCLC Patients

Medical costs of treatment and survival of patients with acute myeloid leukemia in Belgium

Memory CD4 T cell receptor repertoire data mining as a tool for identifying cytomegalovirus serostatus

Modifying the Tumour Microenvironment: Challenges and Future Perspectives for Anticancer Plasma Treatments

Monocyte-Derived Dendritic Cells with Silenced PD-1 Ligands and Transpresenting Interleukin-15 Stimulate Strong Tumor-Reactive T-cell Expansion

Multidisciplinary study of the secondary immune response in grandparents re-exposed to chickenpox

NK cells: key to success of DC-based cancer vaccines?

Natural killer cell immune escape in acute myeloid leukemia.

Natural killer cells and their therapeutic role in pancreatic cancer: A systematic review.

New targets for therapy: antigen identification in adults with B-cell acute lymphoblastic leukaemia

Non-Thermal Plasma as a Unique Delivery System of Short-Lived Reactive Oxygen and Nitrogen Species for Immunogenic Cell Death in Melanoma Cells

Oxidative Stress-Inducing Anticancer Therapies: Taking a Closer Look at Their Immunomodulating Effects

Poly(I:C) as cancer vaccine adjuvant: knocking on the door of medical breakthroughs.

Poly(I:C) enhances the susceptibility of leukemic cells to NK cell cytotoxicity and phagocytosis by DC

Poly(I:C) primes primary human glioblastoma cells for an immune response invigorated by PD-L1 blockade

Preclinical data on the combination of cisplatin and anti-CD70 therapy in non-small cell lung cancer as an excellent match in the era of combination therapy.

Prognostic and predictive aspects of the tumor immune microenvironment and immune checkpoints in malignant pleural mesothelioma

Proinflammatory response of human leukemic cells to dsRNA transfection linked to activation of dendritic cells

Quantification of IFN-gamma produced by human purified NK cells following tumor cell stimulation: comparison of three IFN-gamma assays.

RANK-RANKL Signaling in Cancer of the Uterine Cervix: A Review. ⬇️

RANK/RANKL signaling inhibition may improve the effectiveness of checkpoint blockade in cancer treatment

RNA-based gene transfer for adult stem cells and T cells.